期刊文献+

宫颈非典型类癌合并原位腺癌的临床病理特征分析 被引量:5

Clinicopathologic features of atypical carcinoid combined with adenocarcinoma in situ of uterine cervix
下载PDF
导出
摘要 目的探讨宫颈非典型类癌合并原位腺癌的临床病理特征。方法分析l例宫颈非典型类癌合并原位腺癌的临床表现、病理形态学特征及免疫组化特点,并结合文献进行讨论。结果患者女性,46岁,阴道出血6个月。MR检查提示宫颈占位性病变,行全子宫、双附件及盆腔淋巴结切除手术。肿瘤组织由原位腺癌及神经内分泌肿瘤(非典型类癌)两种组织学形态组成,两种成分各自独立生长。神经内分泌肿瘤CK、CD56、Syn和CD117(+);原位腺癌CK、CEA、p16和CDX2(+)。结论宫颈非典型类癌非常罕见,其合并原位腺癌更属罕见。非典型类癌需要与低分化腺癌、类癌、大细胞神经内分泌癌、腺样基底细胞癌和转移性非典型类癌等鉴别。 Objective To study the clinicopathological features,diagnosis,and differential diagnosis of atypical carcinoid combined with adenocarcinoma in situ( AIS) of the uterine cervix. Methods A case of atypical carcinoid combined with AIS in the uterine cervix was investigated by clinical findings,histopathology and immunohistochemistry,and related literatures were reviewed. Results A 46-year-old woman presented with vaginal bleeding for 6 months. MRI examination showed an uterine cervical mass. The patient was treated with hysterectomy, bilateral salpingoophorectomy and lymphadenectomy. Microscopic examination revealed that the tumor contained two kinds of histological morphology,atypical carcinoid and AIS,which grew independently. Immunohistochemically,CK,CD56,Syn and CD117 were positive in neuroendocrine tumor,while AIS was positive for CK,CEA,p16 and CDX2. Conclusions Atypical carcinoid combined with AIS of the uterine cervix is rare. Differential diagnosis of atypical carcinoid includes poorly-differentiated adenocarcinoma,carcinoid,large cell neuroendocrine tumor,adenoid basal carcinoma and secondary atypical carcinoid.
作者 明健 许斌 辛小川 方婉婷 姜彦多 MING Jian;XU Bin;XIN Xiao-chuan;FANG Worn-ting;JIANG Yon-duo(Department of Pathology, 202 Hospital of China Medical University/202 Hospital of PLA, Shenyang 110812, China;Department of Pathology, Fushun Central Hospital, Fushun 113006, China)
出处 《诊断病理学杂志》 2018年第5期340-344,共5页 Chinese Journal of Diagnostic Pathology
关键词 宫颈 非典型类癌 原位腺癌 临床病理特征 Uterine cervix Atypical carcinoid AIS Clinicopathologic features
  • 相关文献

参考文献2

二级参考文献13

  • 1周柔丽,王永潮,王海英,等主编.医学细胞生物学[M].2版.北京:北京大学医学出版社,2006:316-325.
  • 2World Health Organizalion. WHO/ICD information on centre on human papillomavirus and cervical cancer [EB/OL]. [2014 -06-20]. http://www, who. int/mediacentre/factsheets/fs380/en/.
  • 3Kurman R J, Carcangiu M L, Herrington C, et al. WHO Classi fication o3' Turnouts of Female Reproductive Organs [M]. 4th ed. I.yon.- International Agency for Research on Cancer, 2014:183 -184.
  • 4Andersson S, Mints M, Wilander E, et al. Results of cytolo gy and high risk human papillomavirus testing in females with cervical adenocarcinoma in situ[J]. Oncol Lett, 2013,6(1): 215- 219.
  • 5Zhao C, Li Z, Austin R M. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glan dular neoplasia[J]. AmJ Clin Pathol, 2013,140(1):47 -54.
  • 6Mc Cluggage W G, Shah R, Connolly L E, et al. Intestinal- typecervical adenocarcinoma in situ and adenocarcinoma exhibit a partialimmunophenotype with consistent expression of CDX2 [J]. Int J Gynecol Pathol, 2008,27(1) :92- 100.
  • 7Boyle D P. Stratified mucin producing intraepithelial lesion (smile): report of a case series with associated pathological findings[EB/OL]. [2014 -07-21]. http://onlinelibrary, wiley. com/doi/10. 1111/his. 12498/pdf.
  • 8Me Cluggage W G. Premalignant lesions of the lower femalegenital tract: cervix, vagina and vulva[J]. Pathology, 2013, 45(3) :214-228.
  • 9Liang J, Mittal K R, Wei J J, et al. Utility of pl6INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions[J]. Int J Gynecol Pathol, 2007,26(1) :71-75.
  • 10Mc Cluggage W G. Premalignant lesions of the lower female genital tract: cervix, vagina and vulva[J]. Pathology, 2013,45(3):214-228.

共引文献19

同被引文献20

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部